Abridge
Weak disclosure · high confidence
Carves clinical PHI out to business associate agreements and is silent on AI model training, reserving only generic product-improvement use of non-PHI data; strong state-privacy rights but weak retention, deletion, and security specifics.
What the policy says
Training silent
The policy never says whether inputs are used to train AI models; the closest clause is generic, stating Abridge will conduct research and development to enhance our products, with no training opt-out named.
Strong rights menu
Section 6 grants the right to know, delete, correct, opt out of sale and sharing, and opt out of profiling, with a Do Not Sell or Share link and recognition of Global Privacy Control signals.
Vague retention
Retention is described only as for as long as needed to fulfill the purposes and as long as reasonably necessary, with no day-count and no deletion timeline.
Generic security, no breach clause
Section 8 commits to appropriate administrative, physical, and technical safeguards but names no specific controls like TLS or AES-256, and the policy is silent on breach notification.
Score by area
Details
- Category
- Healthcare
- Modalities
- audio, text
- Processes biometrics
- No
- Policy last updated
- 2025-08-22
- Region scored
- Global / US-default
- Assessed
- 2026-06-20
Each grade reflects our analysis of what an app states in its public privacy policy and terms as of the assessment date. It measures the transparency of those documents, not the company's actual data practices, security, or compliance. Grades are our opinion, offered for general information. Full disclaimer.